318 related articles for article (PubMed ID: 26899197)
21. Diabetic cardiomyopathy: a brief summary on lipid toxicity.
Ke J; Pan J; Lin H; Gu J
ESC Heart Fail; 2023 Apr; 10(2):776-790. PubMed ID: 36369594
[TBL] [Abstract][Full Text] [Related]
22. An overview of the inflammatory signalling mechanisms in the myocardium underlying the development of diabetic cardiomyopathy.
Frati G; Schirone L; Chimenti I; Yee D; Biondi-Zoccai G; Volpe M; Sciarretta S
Cardiovasc Res; 2017 Mar; 113(4):378-388. PubMed ID: 28395009
[TBL] [Abstract][Full Text] [Related]
23. Pathogenesis, Clinical Features and Treatment of Diabetic Cardiomyopathy.
Alonso N; Moliner P; Mauricio D
Adv Exp Med Biol; 2018; 1067():197-217. PubMed ID: 28980272
[TBL] [Abstract][Full Text] [Related]
24. Mitochondrial dysfunction in diabetic cardiomyopathy.
Duncan JG
Biochim Biophys Acta; 2011 Jul; 1813(7):1351-9. PubMed ID: 21256163
[TBL] [Abstract][Full Text] [Related]
25. IL-6: A Potential Role in Cardiac Metabolic Homeostasis.
Xu Y; Zhang Y; Ye J
Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30134607
[TBL] [Abstract][Full Text] [Related]
26. Salacia oblonga root improves cardiac lipid metabolism in Zucker diabetic fatty rats: modulation of cardiac PPAR-alpha-mediated transcription of fatty acid metabolic genes.
Huang TH; Yang Q; Harada M; Uberai J; Radford J; Li GQ; Yamahara J; Roufogalis BD; Li Y
Toxicol Appl Pharmacol; 2006 Jan; 210(1-2):78-85. PubMed ID: 16129467
[TBL] [Abstract][Full Text] [Related]
27. Abnormal Myocardial Dietary Fatty Acid Metabolism and Diabetic Cardiomyopathy.
Carpentier AC
Can J Cardiol; 2018 May; 34(5):605-614. PubMed ID: 29627307
[TBL] [Abstract][Full Text] [Related]
28. Lipid partitioning during cardiac stress.
Kolwicz SC
Biochim Biophys Acta; 2016 Oct; 1861(10):1472-80. PubMed ID: 27040509
[TBL] [Abstract][Full Text] [Related]
29. Role of cardiac steatosis and lipotoxicity in obesity cardiomyopathy.
Zhang Y; Ren J
Hypertension; 2011 Feb; 57(2):148-50. PubMed ID: 21220703
[No Abstract] [Full Text] [Related]
30. Lipotoxicity as a therapeutic target in obesity and diabetic cardiomyopathy.
Nakamura M
J Pharm Pharm Sci; 2024; 27():12568. PubMed ID: 38706718
[TBL] [Abstract][Full Text] [Related]
31. Non-ischemic diabetic cardiomyopathy may initially exhibit a transient subclinical phase of hyperdynamic myocardial performance.
Hensel KO
Med Hypotheses; 2016 Sep; 94():7-10. PubMed ID: 27515189
[TBL] [Abstract][Full Text] [Related]
32. Role of microRNA in diabetic cardiomyopathy: From mechanism to intervention.
Guo R; Nair S
Biochim Biophys Acta Mol Basis Dis; 2017 Aug; 1863(8):2070-2077. PubMed ID: 28344129
[TBL] [Abstract][Full Text] [Related]
33. The interplay between autophagy and apoptosis in the diabetic heart.
Ouyang C; You J; Xie Z
J Mol Cell Cardiol; 2014 Jun; 71():71-80. PubMed ID: 24513079
[TBL] [Abstract][Full Text] [Related]
34. Pathophysiology and Treatment of Diabetic Cardiomyopathy and Heart Failure in Patients with Diabetes Mellitus.
Nakamura K; Miyoshi T; Yoshida M; Akagi S; Saito Y; Ejiri K; Matsuo N; Ichikawa K; Iwasaki K; Naito T; Namba Y; Yoshida M; Sugiyama H; Ito H
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408946
[TBL] [Abstract][Full Text] [Related]
35. The PKD inhibitor CID755673 enhances cardiac function in diabetic db/db mice.
Venardos K; De Jong KA; Elkamie M; Connor T; McGee SL
PLoS One; 2015; 10(3):e0120934. PubMed ID: 25798941
[TBL] [Abstract][Full Text] [Related]
36. Angiotensin 1-7 ameliorates diabetic cardiomyopathy and diastolic dysfunction in db/db mice by reducing lipotoxicity and inflammation.
Mori J; Patel VB; Abo Alrob O; Basu R; Altamimi T; Desaulniers J; Wagg CS; Kassiri Z; Lopaschuk GD; Oudit GY
Circ Heart Fail; 2014 Mar; 7(2):327-39. PubMed ID: 24389129
[TBL] [Abstract][Full Text] [Related]
37. Human embryonic stem cell-derived cardiomyocytes as an in vitro model to study cardiac insulin resistance.
Geraets IME; Chanda D; van Tienen FHJ; van den Wijngaard A; Kamps R; Neumann D; Liu Y; Glatz JFC; Luiken JJFP; Nabben M
Biochim Biophys Acta Mol Basis Dis; 2018 May; 1864(5 Pt B):1960-1967. PubMed ID: 29277329
[TBL] [Abstract][Full Text] [Related]
38. Chronic Co-Administration of Sepiapterin and L-Citrulline Ameliorates Diabetic Cardiomyopathy and Myocardial Ischemia/Reperfusion Injury in Obese Type 2 Diabetic Mice.
Baumgardt SL; Paterson M; Leucker TM; Fang J; Zhang DX; Bosnjak ZJ; Warltier DC; Kersten JR; Ge ZD
Circ Heart Fail; 2016 Jan; 9(1):e002424. PubMed ID: 26763290
[TBL] [Abstract][Full Text] [Related]
39. Cardiac lipotoxicity: molecular pathways and therapeutic implications.
Drosatos K; Schulze PC
Curr Heart Fail Rep; 2013 Jun; 10(2):109-21. PubMed ID: 23508767
[TBL] [Abstract][Full Text] [Related]
40. The role of CD36 in the regulation of myocardial lipid metabolism.
Kim TT; Dyck JR
Biochim Biophys Acta; 2016 Oct; 1861(10):1450-60. PubMed ID: 26995462
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
